Cargando…
Effect of almitrine bismesylate and inhaled nitric oxide on oxygenation in COVID-19 acute respiratory distress syndrome
Autores principales: | Cardinale, Michael, Esnault, Pierre, Cotte, Jean, Cungi, Pierre J., Goutorbe, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Société française d'anesthésie et de réanimation (Sfar). Published by Elsevier Masson SAS.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271846/ https://www.ncbi.nlm.nih.gov/pubmed/32505755 http://dx.doi.org/10.1016/j.accpm.2020.05.014 |
Ejemplares similares
-
Role of almitrine bismesylate in managing refractory hypoxemia in COVID19 acute respiratory distress syndrome
por: Nair, Abhijit S., et al.
Publicado: (2021) -
Use of Almitrine and Inhaled Nitric Oxide in ARDS Due to COVID-19
por: Laghlam, Driss, et al.
Publicado: (2021) -
Rescue therapy with inhaled nitric oxide and almitrine in COVID-19 patients with severe acute respiratory distress syndrome
por: Bagate, François, et al.
Publicado: (2020) -
Dialysis disequilibrium syndrome in neurointensive care unit: the benefit of intracranial pressure monitoring
por: Esnault, Pierre, et al.
Publicado: (2012) -
Efficacy of Almitrine in the Treatment of Hypoxemia in Sars-Cov-2 Acute Respiratory Distress Syndrome
por: Barthélémy, Romain, et al.
Publicado: (2020)